https://www.marketscreener.com/quote/stock/NOVO-NORDISK-A-S-1412980/news/Novo-Nordisk-A-S-Once-weekly-semaglutide-2-0-mg-demonstrates-superior-reduction-in-HbA1c-vs-once-w-31803329/?utm_source=telegram&utm_medium=social&utm_campaign=share